Think Surgical yesterday reported a funding round worth $134 million for the robot-assisted orthopedic surgery device it makes.
The Fremont, Calif.-based company’s TSolution One is designed for knee and hip arthroplasties. It’s approved in the U.S. and Europe for total hip procedures; in December 2017 the company won CE Mark approval for a total knee indication and is running a U.S. investigation device exemption study seeking an FDA nod.
In a regulatory filing yesterday Think Surgical said an offering of debt, options, warrants and other securities brought in $134.2 million of its $140 million goal. Six unnamed investors participated, according to the filing.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.